Main > > >HEPATOLOGY.

Acute Hepatic Porphyria (AHP). Treat.:
Givosiran Inj. for SubCutaneous (SC)
Use.
Genetic Disease.
RNA Interference.
EU Approval Date : 2020. 03.03.
USA Approval Date: 2019. 11.20.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 04.08.




Chronic Liver Disease Scheduled to undergo a Procedure. Thrombocytopenia
(low blood platelet count). TREAT.:
Avatrombopag Tablets.
USA Approval Date: 2018. 05.21.
(*) Company; Patent APPs.; TradeMark &
Web-Site Available on Request.
UpDate: 2018. 05.22.




Cirrhosis. Edema. Management: DiUretics. SpironoLactone Oral
Suspension 25 mg/5 mL.
USA Approval Date: 2017. 08.07.
USA Launch Date: 2017. 10.30.
(*) Company; Patents; TradeMark & Web-Site Available on
Request.
UpDate: 2018. 01.11.




DIAG.>IMAG.>MRI>CAD>Version 2.0
EU Approval
USA Approval Date: 2017. 11.27.
(*) Company & TradeMark Available on
Request.
UpDate: 2017. 11.28




DIAG.>IMAG.>US (UltraSound).
USA 510(k) Clearance Date: 2018. 02.01.
(*) Company; Patent; TradeMark & Web-Site Available on
Request.
UpDate: 2018. 02.03.




Hepatitis B Virus Infection. DIAG.:
AptimaŽ HBV Quant Assay for quantitation of hepatitis B viral load on the fully automated PantherŽ system.
USA PMA Approval Date: 2018. 01.25.
(*) Company: Hologic Inc.
UpDate: 2018. 01.26.




Hepatitis B Virus Infection. TREAT.:
Entecavir Tablets. GENERIC.
USA Final Approval Date: 2018. 03.27.
(*) Company: Breckenridge Pharmaceutical
www.bpirx.com
UpDate: 2018. 03.28.




Hepatitis B Virus Infection. TREAT.:
Tenofovir alafenamide Tab.
Approved in EU; JP & USA
CN Approval Date: 2018. 11.18.
(*) Company : Gilead
Patent : Expired
TradeMark: Vemlidy
Web-Site : www.vemlidy.com
UpDate: 2018. 11.20.




Hepatitis C Virus Infection. TREAT.: Glecaprevir+Pibrentas
vir. [for Adults across all major GenoTypes (GT1-6)].
Glecaprevir: Protease Inhibitor.
CA Approval Date: 2017. 08.17.
EU Approval Date: 2017. 07.28.
JP Approval Date: 2017. 09.27.
JP Launch Date: 2017. 11.30.
USA Approval Date: 2017. 08.03.
(*) Company; Patent>Assignee & Trade-
Mark Available on Request.
UpDate: 2017. 12.01.




Hepatitis C Virus Infection. TREAT.:
Ledipasvir+Sofosbuvir 90 mg/400 mg Ta-
blets.
CN Approval Date : 2018. 12.04.
EU Approval Date : 2014. 11.17.
USA Approval Date: 2014. 10.10.
(*) Company; Patents; TradeMark & Web-
Site Available on Request
UpDate: 2018. 12.06.




Hepatitis C Virus Infection. TREAT.:
Sofosbuvir 400 mg Tablets.
CN Approval Date : 2017. 09.25.
EU Approval Date : 2014. 01.15.
JP Approval Date : 2015. 03.26.
USA Approval Date: 2013. 12.06>
>Adults
USA Approval Date: 2017. 04.07>
>Pediatric Patients 12 Years and Older
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 12.06.




Liver Function. Alanine Aminotransferase (ALT) Measurement
Method.
USA Launch Date: 2017. 12.19.
(*) Company & TradeMark Available on
Request.
UpDate: 2017. 12.20.




Non-Alcoholic SteatoHepatitis (NASH)
TREAT.: Long-Acting Fibroblast Growth Factor 21 (FGF21) Analogue. (U)
Development Status: Phase II
(*) Company; Patents & Web-Site Avai-
lable on Request.
UpDate: 2018. 07.17.




Porphyria. Treat.: Human Hemin for Inj.
CA Launch Date: 2018. 11.16.
(*) Company : Recordati.
TradeMark: PANHEMATIN
Web-Site : www.panhematin.com
UpDate: 2018. 11.17.




Primary Sclerosing Cholangitis (PSC).
Diag.: Biliary Visualization Software.
EU CE Mark Date : ?
USA Clearance Date: 2019. 01.23.
(*) Company; Patent; Product Name &
Web-Site Available on Request.
UpDate: 2021. 02.21.


>HEPATOLOGY.'s products
This section has no products